Torrent Pharmaceuticals Limited Announces Dissolution of Philippines Subsidiary
Torrent Pharmaceuticals Limited has announced the voluntary dissolution of its wholly owned subsidiary, Curatio Inc., which is domiciled in the Philippines. The dissolution became effective as of July 10, 2026.The company received formal communication regarding the dissolution on July 17, 2026. The entity was dissolved through a shortening of the term of existence via an amendment in the Articles of Incorporation.
Financial Contribution and Scale
During the financial year ending March 31, 2026, Curatio Inc. contributed a negligible amount to the consolidated figures of the company. The subsidiary reported zero turnover for the period. Regarding net worth, the entity held Rs 1.3 Crores, representing 0.02% of the total.The following table summarizes the financial standing of the subsidiary during the last financial year:
| Particulars | Details (as of March 31, 2026) |
|---|---|
| Turnover for FY 2025-26 | Nil (0%) |
| Net Worth for FY 2025-26 | Rs 1.3 Crores (0.02%) |
As the entity has been dissolved, there are no applicable details regarding sale agreements, expected completion dates of disposal, or consideration received from any transaction.
TORNTPHARM Stock Price Movement
Shares of Torrent Pharmaceuticals Limited on Friday slipped by 4.82% to settle at ₹4,747. The stock saw a total trading volume of 1.40 million shares as it fell from the previous close.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.